CardioMEMS Registers for Initial Public Offering

ATLANTA, GA/PRNewswire/ -- CardioMEMS Inc. announced today that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission for a proposed initial public offering of shares of its common stock. All of the shares in the proposed offering are being sold by CardioMEMS.

The underwriters of the offering will be Banc of America Securities LLC as sole book-running manager, CIBC World Markets Corp. as co-lead manager, and Jefferies & Company, Inc. and Pacific Growth Equities, LLC as co-managers. The number of shares to be offered and the price range for the offering have not yet been determined.

The offering will be made only by means of a prospectus. When available, a copy of the preliminary prospectus relating to the offering may be obtained from Banc of America Securities LLC, c/o Prospectus Department, 100 West 33rd Street, New York, NY 10001, [email protected], or CIBC World Markets Corp., c/o USE Prospectus Department, 425 Lexington Avenue, 5th floor, New York, New York 10017, [email protected], telephone (212) 667-7200 or (866) 895-5637, facsimile (212) 667-6303.

A registration statement relating to these securities has been filed with the Securities and Exchange Commission but has not yet become effective. These securities may not be sold nor may offers to buy be accepted prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of these securities in any state in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state.

About CardioMEMS, Inc.
CardioMEMS, Inc. is a medical device company that has developed and is commercializing a proprietary wireless sensing and communication technology for the human body. CardioMEMS' technology platform is designed to improve the management of severe chronic cardiovascular diseases such as heart failure, aneurysms and hypertension.

Contact: Harold W. Ingalls, chief financial officer of CardioMEMS, Inc., 1-404-920-6700

Suggested Articles

Analysts predict 5G shipments to explode in number in 2020

Based on research by two MIT economists, Khanna’s multibillion-dollar plans foresees land-grant approach to tech education and tech hubs

Semtech chips to power gateways and sensors on ships serviced by Wilhelmsen of Norway